Premium
Zenas BioPharma Inc (ZBIO)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| FMR LLC | Institution | 9 082 000 | 14,39% | US$ 166,93M | 2026-03-31 |
| SR One Capital Management, LP | Institution | 5 037 854 | 7,98% | US$ 92,60M | 2026-03-31 |
| InnoCare Pharma Limited | Institution | 5 000 000 | 7,92% | US$ 91,90M | 2025-10-09 |
| New Enterprise Associates, Inc. | Institution | 4 023 219 | 6,37% | US$ 73,95M | 2026-03-31 |
| Enavate Sciences | Institution | 3 919 159 | 6,21% | US$ 72,03M | 2026-03-31 |
| Federated Hermes, Inc. | Institution | 3 127 031 | 4,95% | US$ 57,47M | 2026-03-31 |
| Xencor, Inc. | Institution | 3 098 380 | 4,91% | US$ 56,95M | 2026-03-12 |
| NEA 18 Venture Growth Equity, L.P. | Institution | 2 613 948 | 4,14% | US$ 48,04M | 2024-09-16 |
| Longitude Capital Management Co., LLC | Institution | 2 607 199 | 4,13% | US$ 47,92M | 2026-03-12 |
| Polar Capital Holdings Plc | Institution | 2 548 444 | 4,04% | US$ 46,84M | 2026-03-31 |
| Capital Research and Management Company | Institution | 2 434 000 | 3,86% | US$ 44,74M | 2026-03-31 |
| Fairmount Funds Management LLC | Institution | 2 359 025 | 3,74% | US$ 43,36M | 2026-03-31 |
| Fairmount Healthcare Fund II L.P. | Institution | 2 359 025 | 3,74% | US$ 43,36M | 2026-03-31 |
| BlackRock, Inc. | Institution | 2 037 548 | 3,23% | US$ 37,45M | 2026-03-31 |
| Sr One Capital Fund Ii Aggregator, Lp | Institution | 1 946 564 | 3,08% | US$ 35,78M | 2025-10-09 |
| NVP Associates, LLC | Institution | 1 838 482 | 2,91% | US$ 33,79M | 2026-03-31 |
| Longitude Venture Partners IV, L.P. | Institution | 1 832 669 | 2,90% | US$ 33,68M | 2026-03-12 |
| Tellus BioVentures, LLC | Institution | 1 786 039 | 2,83% | US$ 32,83M | 2026-05-18 |
| State Street Global Advisors, Inc. | Institution | 1 470 923 | 2,33% | US$ 27,04M | 2026-03-31 |
| Norwest Venture Partners XVI, LP. | Institution | 1 438 482 | 2,28% | US$ 26,44M | 2024-09-13 |
| Bristol-Myers Squibb Company | Institution | 1 414 781 | 2,24% | US$ 26,00M | 2024-09-13 |
| Wellington Management Group LLP | Institution | 1 246 053 | 1,97% | US$ 22,90M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 1 245 391 | 1,97% | US$ 22,89M | 2026-03-31 |
| SR One Capital Opportunities Fund I, LP | Institution | 1 173 395 | 1,86% | US$ 21,57M | 2025-10-09 |
| Silverarc Capital Management, LLC | Institution | 1 135 935 | 1,80% | US$ 20,88M | 2026-03-31 |
| AllianceBernstein L.P. | Institution | 897 321 | 1,42% | US$ 16,49M | 2026-03-31 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | Institution | 801 624 | 1,27% | US$ 14,73M | 2024-09-16 |
| EcoR1 Capital, LLC | Institution | 789 500 | 1,25% | US$ 14,51M | 2026-03-31 |
| Longitude Prime Fund, L.P. | Institution | 774 530 | 1,23% | US$ 14,24M | 2026-03-12 |
| Balyasny Asset Management L.P. | Institution | 667 070 | 1,06% | US$ 12,26M | 2026-03-31 |
| ArrowMark Colorado Holdings, LLC | Institution | 658 909 | 1,04% | US$ 12,11M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 655 785 | 1,04% | US$ 12,05M | 2026-03-31 |
| Pivotal BioVenture Partners LLC | Institution | 591 991 | 0,94% | US$ 10,88M | 2026-03-31 |
| Woodline Partners LP | Institution | 590 525 | 0,94% | US$ 10,85M | 2026-03-31 |
| Great Point Partners, LLC | Institution | 524 066 | 0,83% | US$ 9,63M | 2026-03-31 |
| Mr. Leon Moulder | Initiés | 520 083 | 0,82% | US$ 9,56M | 2026-05-18 |
| Rock Springs Capital Management LP | Institution | 502 077 | 0,80% | US$ 9,23M | 2026-03-31 |
| Marshall Wace LLP | Institution | 501 928 | 0,80% | US$ 9,23M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
